Protein/mRNA expression of c*jun*, *jun*B, *jun*D, and c*fos*, levels of the mRNA-destabilizing proteins AUF-1 and tristetraprolin (TTP), and levels of the mRNA-stabilizing protein HuR were assessed in synovial membranes (SM) from patients with rheumatoid arthritis (RA), osteoarthritis (OA), joint trauma (JT), or postmortem normal controls (NC) using ELISA/western blotting and real-time RT-PCR.

Protein expression for *Jun/Fos*proto-oncogenes was significantly increased (JunB and JunD) or numerically increased (cJun and cFos) in RA SM compared with OA, JT, and NC. In contrast, *jun/fos*mRNA expression was significantly decreased (c*jun*and *jun*B) or numerically decreased (*jun*D and c*fos*) in RA and OA compared with JT or NC.

Protein expression levels of AUF-1 were comparable among the different groups. For TTP and HuR, interestingly, significantly increased protein expression was observed in RA and OA SM compared with either JT or NC.

Discrepancies between the mRNA and protein expression for several *jun/fos*genes suggest broad alterations of post-transcriptional processes in the RA SM. Whereas increased levels of mRNA-destabilizing TTP may contribute to the low levels of *jun/fos*mRNA, abundant mRNA-stabilizing HuR may augment translation of the remaining mRNA into protein. As a consequence, both increased expression of AP-1-dependent target genes by the activating transcription factors c*Jun*/c*Fos*and modified binding activity of the resulting AP-1 complexes via the action of deactivating *Jun*B and *Jun*D may contribute to the pathogenesis of RA.
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